Home/Filings/4/0001209191-17-047864
4//SEC Filing

Sullivan Eric 4

Accession 0001209191-17-047864

CIK 0001293971other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 4:02 PM ET

Size

22.9 KB

Accession

0001209191-17-047864

Insider Transaction Report

Form 4
Period: 2017-08-03
Sullivan Eric
Principal Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2017-08-04$50.51/sh+201$10,1535,875 total
  • Exercise/Conversion

    Common Stock

    2017-08-04$56.30/sh+244$13,7376,119 total
  • Sale

    Common Stock

    2017-08-04$95.21/sh445$42,3705,674 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2017-08-03250750 total
    Exercise: $20.70Exp: 2023-12-02Common Stock (250 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-08-03166854 total
    Exercise: $24.47Exp: 2024-03-03Common Stock (166 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-08-042015,868 total
    Exercise: $50.51Exp: 2026-03-01Common Stock (201 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-08-042448,558 total
    Exercise: $56.30Exp: 2026-08-01Common Stock (244 underlying)
  • Exercise/Conversion

    Common Stock

    2017-08-03$20.70/sh+250$5,1755,924 total
  • Exercise/Conversion

    Common Stock

    2017-08-03$24.47/sh+166$4,0626,090 total
  • Sale

    Common Stock

    2017-08-03$92.35/sh416$38,4185,674 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    300
Footnotes (6)
  • [F1]The range in prices for the transaction reported on this line was $95.10 to $95.30. The average weighted price was $95.2128. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]Equity grants held by the reporting person's spouse, who is employed by the issuer
  • [F3]This option vests over a four-year period, at a rate of twenty-five percent (25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
  • [F4]This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
  • [F5]This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017, and in 36 equal monthly installments.
  • [F6]This option vests over a four-year period, at a rate of twenty-five percent (25%) on July 4, 2017 and in 36 equal monthly installments thereafter.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001601797

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 4:02 PM ET
Size
22.9 KB